The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the max…

Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more

~Estimated

~$10 – $8,750

Jazz PharmaceuticalsNCT04541082

Phase 2

A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma

The purpose of this research study is to determine the effects bevacizumab (the study drug) combined with Optune (the study device) tumor treatment field thera…

Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more

~Estimated

~$10 – $6,250

Northwestern UniversityNCT02847559